HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection.

AbstractBACKGROUND:
Recent availability of tests for Helicobacter pylori antigens in stool samples has provided potentially useful tools for epidemiological studies and clinical settings. The aim of this study was to evaluate a monoclonal antibody-based H. pylori antigen stool test in the primary diagnosis of H. pylori infection, and to study the test performance after patients were treated with lanzoprazole, and after eradication therapy.
METHODS:
The study included 122 dyspeptic patients. At gastroscopy, biopsy specimens were obtained for culture and histology. Stool antigen and [14C]-urea breath tests were performed concurrently. Positive culture alone or a positive [14C]-urea breath test in combination with positive histology defined the reference standard. Forty-three Hp +ve patients were treated with lanzoprazole for 2 to 4 weeks, and stool antigen tests were performed on days 1 and 7 post-treatment. After eradication therapy, 32 patients were re-examined for H. pylori infection.
RESULTS:
Prevalence of H. pylori was 44.3%. Sensitivity and specificity for the stool antigen test in the primary diagnosis of H. pylori infection were 98% and 94%, with positive and negative likelihood ratios of 16.7 and 0.02, respectively. All patients had positive stool tests immediately after lanzoprazole treatment, whereas 2 patients had negative stool tests after 7 days. Triple therapy rendered all patients stool test negative.
CONCLUSIONS:
The monoclonal antibody-based stool antigen test is an accurate tool in the primary diagnosis of H. pylori infection and after eradication therapy. Lanzoprazole treatment does not influence the clinical performance of the test.
AuthorsA M Asfeldt, M-L Løchen, B Straume, S E Steigen, J Florholmen, R Goll, O Nestegard, E J Paulssen
JournalScandinavian journal of gastroenterology (Scand J Gastroenterol) Vol. 39 Issue 11 Pg. 1073-7 (Nov 2004) ISSN: 0036-5521 [Print] Norway
PMID15545164 (Publication Type: Evaluation Studies, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Antibodies, Monoclonal
  • Antigens, Bacterial
  • Proton Pump Inhibitors
  • Lansoprazole
  • Omeprazole
Topics
  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal
  • Antigens, Bacterial (analysis)
  • Enzyme-Linked Immunosorbent Assay
  • Feces (microbiology)
  • Female
  • Helicobacter Infections (diagnosis, drug therapy)
  • Helicobacter pylori (immunology, isolation & purification)
  • Humans
  • Lansoprazole
  • Male
  • Middle Aged
  • Omeprazole (analogs & derivatives, therapeutic use)
  • Peptic Ulcer (diagnosis, microbiology)
  • Proton Pump Inhibitors
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: